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The two new studies uncover a dual 
role for agonist-induced phosphorylation 
of the R-Smad linker region. It is not only 
required for ubiquitin-proteasomal degra-
dation of activated R-Smads, but it is also 
important for achieving their maximum 
transcriptional activity. The last minutes 
of Smads before their degradation are 
marked by a boost in their activity due to 
phosphorylation. The increased activity is 
likely to be important for Smad-mediated 
TGF-β/BMP signaling in the induction 
of target gene expression, neural dif-
ferentiation, and tissue patterning. This 
scenario represents a new example of 
what we have learned from studying the 
nuclear hormone receptors, i.e., the activ-
ity of transcription factors is often, if not 
always, coupled to their destruction.
The two new studies stimulate many 
interesting questions. Gao et al. showed 
that TGF-β-induced phosphorylation of 
the Thr179 residue is critical for binding 
of Nedd4L. However, signaling via the 
epidermal growth factor and MAPK also 
induces Thr179 phosphorylation but can-
not promote Nedd4L binding. How does 
the same phosphorylation event generate 
two such different outcomes? One expla-
nation could be the different intracellular 
locales where these different phospho-
rylation events take place. Smurf1 and 
Nedd4L are closely related E3 ubiquitin 
ligases, both recognizing the PY motif 
in their substrates via their WW domain. 
What is the structural basis to discriminate 
the Smurf1-Smad1 and Nedd4L-Smad3 
interactions? Why is it that C-terminal-
tail phosphorylation and Smad4 are both 
required for CDK8/9 to phosphorylate the 
linker region of R-Smads? Does Smad4 
help to recruit CDK8/9 to their R-Smad 
substrates? Given that YAP and Smurf 
bind to the same linker phosphorylation 
sites, what then are the mechanisms that 
control the balance of these functionally 
opposite interactions and that mediate the 
switch from activation to degradation? In 
addition, YAP activity is regulated by Hippo 
signaling. It will be interesting to investigate 
whether there is functional convergence of 
the BMP and Hippo signaling pathways in 
the control of cell proliferation and organ 
size. On the other hand, although YAP 
is an important coactivator of Smad1 in 
BMP signaling, it may not be a major pro-
moter of Smad2/3 activity. Is there, then, a 
counterpart to YAP that collaborates with 
Smad2/3? Finally, dephosphorylation of 
activated R-Smads by phosphatases has 
been shown to play an important role in 
terminating Smad function. As Gao et al. 
point out, it is still an open question which 
signaling turn off mechanism is used in 
which physiological setting. Answers to 
these questions will surely increase our 
understanding of the molecular basis of 
TGF-β/BMP regulation and the crosstalk 
between different signaling pathways.
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The GTPase Cdc42 specifies polarity in various biological processes. Kesavan et al. (2009) now 
demonstrate that Cdc42 also regulates epithelial cell polarity in the developing mouse pancreas, where 
it is required for tubule formation and maintenance. Furthermore, the polarization of epithelial tissue 
influences the differentiation of pancreatic progenitor cells, linking cell polarity to cell specification.Tissue architecture provides an environ-
ment for cells to produce and respond to 
signals. In order to develop into functional 
organs, cells expressing ligands and cells 
expressing receptors have to be located at 660 Cell 139, November 13, 2009 ©2009 Elsthe right place at the right time to establish 
proper signaling cascades. A recent study 
showed that establishment of correct epi-
thelial polarity is essential for epithelial 
specification and organogenesis in the evier Inc.mouse mammary gland (McCaffrey and 
Macara, 2009). Mammary gland progeni-
tor cells lacking Par3, a component of the 
Par3/Par6/aPKC polarity complex, failed 
to differentiate into either myoepithelia or 
lumenal epithelia. In addition, 
the Par3-depleted mammary 
epithelia had abnormal ductal 
structures, suggesting a link 
between tissue organization, 
or polarity, and the specifica-
tion of cell fate. A new study 
by Kesavan et al. (2009) in this 
issue of Cell now examines 
the role of the polarity regu-
lator Cdc42 in the formation 
of tubules in the mouse pan-
creas. Kesavan and colleagues 
report that Cdc42 initiates for-
mation of the apical lumens 
that ultimately combine to form 
tubules, and that these epithe-
lial structures instruct pancre-
atic progenitor cell differentia-
tion and specification (Figure 
1). These findings establish a 
link between cell polarization 
and tissue differentiation dur-
ing organ development. 
Cdc42, a Rho family GTPase, 
plays essential roles in a vari-
ety of biological processes, 
such as formation of the 
cytoskeleton, vesicle traffick-
ing, and establishment of api-
cal polarity. In their new work, 
Kesavan et al. examine the role 
of Cdc42 in the polarization of 
epithelial cells and in lumen 
formation in the developing 
pancreas. The authors first 
show that tubular structures 
in the mouse pancreas in vivo 
are generated through fusion 
of existing microlumens. Initially, clusters 
of polarized cells, with apical surfaces 
facing the lumen, form microlumens. As 
more cells become polarized, additional 
lumenal structures form, ultimately fusing 
into a tubular network. More specifically, 
the authors demonstrate that atypical 
protein kinase C (aPKC), a downstream 
effector of Cdc42, is required for the 
coalescence of microlumens into tubu-
lar structures. These tubular structures 
mature to form a single layer of polar-
ized epithelium inside the mouse pan-
creas. Tissue-specific ablation of Cdc42 
results in a fragmented pancreatic epi-
thelia and large cellular aggregates that 
lack tubules (Figure 1). Using this in vivo 
model, the authors show that Cdc42 is 
required for establishing microlumens 
early during development of the pan-
creas and subsequently for maintaining 
the apical polarity of pancreatic tubules.
As pancreatic cells lacking Cdc42 
form large aggregates with no lumen, 
the authors wondered whether this 
altered tissue structure affected cell 
specification, namely the lineage com-
mitment of multipotent pancreatic pro-
genitor cells. Based on genome-wide 
transcription factor expression analysis, 
previous work had identified a multipo-
tent compartment at the tip of pancre-
atic branches containing progenitors 
that differentiate into exocrine, endo-
crine, and duct cells at different stages 
of organogenesis (Zhou et al., 2007). So, 
without the correct branching structure 
in the Cdc42-ablated pancreas, would 
these progenitor cells differ-
entiate properly? The authors 
report that ablating Cdc42 in 
the mouse pancreas not only 
disrupted the epithelial struc-
ture but also randomized the 
distribution of progenitors in 
the pancreas, increased the 
relative percentage of undif-
ferentiated cells, and led to 
an increase in the number of 
progenitor cells differentiat-
ing into acinar cells at the 
expense of endocrine com-
mitment. The authors reason 
that the increase in differenti-
ation into the acinar lineage is 
due to misorganization of the 
extracellular matrix, and that 
the failure of Cdc42-ablated 
cells to commit to the endo-
crine lineage is perhaps due 
to disrupted Notch signaling 
in the mutant pancreas. These 
results demonstrate that epi-
thelial structures are engi-
neered under the guidance 
of Cdc42 and are required for 
the differentiation of pancre-
atic progenitor cells.
One striking result in the 
Kesavan et al. (2009) study is 
that a drug called Y27632, a 
Rho kinase (ROCK) inhibitor, 
restored tube formation in 
pancreatic epithelia lacking 
Cdc42. ROCK is a negative 
regulator of the Par3/Par6/
aPKC polarity complex, and 
Par3 phosphorylation by ROCK pre-
vents its interaction with the complex. 
Inhibition of ROCK may rescue the 
tubulation defects in the Cdc42-ablated 
mouse pancreas by allowing activation 
of the Par3/Par6/aPKC complex, thus 
restoring correct polarity to the epithe-
lia. However, a recent study suggested 
that Y27632 not only inhibits ROCK 
but also efficiently inhibits aPKC activ-
ity (Atwood and Prehoda, 2009), which 
points to another interpretation. The res-
cue seen in Cdc42 mutants treated with 
Y27632 might be a combined effect of 
inhibiting both ROCK and aPKC activity. 
If so, why would the inhibition of ROCK 
upstream of aPKC, and the inhibition 
of aPKC downstream of ROCK, rescue 
the Cdc42 mutant phenotype? Further 
figure 1. cdc42 Regulates Tubule formation in the Pancreas
Tubes form in the developing mouse pancreas through expansion and fusion 
of existing microlumens. At embryonic day 11 and 12 (E11–E12), microlumens 
with visible apical surfaces (blue) form within the pancreas. At E12.5, these 
microlumens start to coalesce into tubular structures. This process requires 
activation of atypical protein kinase C (aPKC), a downstream effector of the 
master polarity protein, Cdc42. Between E12.5 and E15.5, lumenal structures, 
which are generated from the microlumens, coalesce and mature to form a 
single layer of polarized epithelium inside the mouse pancreas. Tissue-specif-
ic loss of Cdc42 results in fragmented pancreatic epithelia and large cellular 
aggregates that lack tubules. Furthermore, the failure to establish proper tis-
sue structure in the pancreatic epithelia lacking Cdc42 causes the aberrant 
differentiation of pancreatic progenitor cells and interferes with cell specifica-
tion in the developing pancreas. Adapted from Kesavan et al. (2009).Cell 139, November 13, 2009 ©2009 Elsevier Inc. 661
experiments, especially to determine 
the activity status of aPKC, will hope-
fully solve this puzzle.
The Kesavan et al. (2009) study 
demonstrates how tubules form in the 
mouse pancreas and how Cdc42 con-
trols polarization of epithelial tissues, 
which is required for this process. Most 
strikingly, Cdc42 controls the forma-
tion of the extracellular matrix, and the 
resulting microenvironment then deter-
mines cell fate. These results raise some 
questions about the function of Cdc42 
and its regulation. Since the discovery 
of Cdc42 in 1990, numerous studies 
have shown that this “master polarity” 
protein plays essential roles in a vari-
ety of biological processes. The activ-
ity of Cdc42 depends on its nucleotide 
binding state: the GTP-bound Cdc42 is 
active, whereas the GDP-bound form is 
inactive. Families of GTPase-activating 
proteins (GAPs), guanine nucleotide 
exchange factors (GEFs), and guanine 662 Cell 139, November 13, 2009 ©2009 Elsnucleotide dissociation inhibitors have 
been shown to regulate the activity of 
Cdc42. It is clear that these regulators do 
not affect just one small GTPase. Grow-
ing evidence suggests that GTPases can 
influence the activity of each other. For 
example, FilGAP is regulated by Rho to 
control Rac activity (Ohta et al., 2006). 
In another case, Cool-2/a-Pix, a GEF, 
is a target of Cdc42 and activates Rac 
(Baird et al., 2005). It seems likely, then, 
that Cdc42 signaling is also highly con-
nected to other small GTPase-signaling 
pathways. Furthermore, the function of 
Cdc42 is regulated not only by its activ-
ity status but also by its localization in 
the cell. Recent studies have suggested, 
for instance, that apical recruitment of 
active Cdc42 via phosphatidylinosi-
tol 4-5-bisphosphate controls lumen 
formation in epithelial tissues (Martin-
Belmonte et al., 2007). Thus, a pressing 
research direction for the field of polar-
ity is elucidating the plasticity of Cdc42, evier Inc.including the spatial-temporal activation 
of Cdc42 activity, activation-inactivation 
oscillations, and functional interactions 
with other small GTPases.
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